2026 NPPES data Specialist NPI 1669441283 M.D.
Verify on CMS →

REYMOND MEADAA, M.D.

Specialist in ALEXANDRIA, Louisiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
4K
Medicare Part D claims · 521 beneficiaries · Specialist avg: 1K
Generic prescribing
89%
generic claims · 11% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$284.43
15 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

REYMOND MEADAA, M.D. filed 4,491 Medicare Part D claims in 2023 as a Specialist in ALEXANDRIA, Louisiana, prescribing 89% generic.

4K
Part D claims, 2023
89%
generic prescribing
$284.43
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

REYMOND MEADAA, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

4,491 Top 7% higher than 93% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about REYMOND MEADAA, M.D.?

Quality data not reported

NPI registry status

Active

Issued 03/16/2006

NPI 1669441283

Primary specialty

Specialist

High-volume

69,658 US NPIs in this specialty

Medicare Part D claims

4,491 205% vs specialty avg

2023 prescription claims

Specialty avg: 1,474

Specialty distribution in Louisiana

How Specialist compares to other specialties among Louisiana providers

Louisiana providers

Specialist share within Louisiana

1. Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Specialist share within Louisiana

Specialty board-certification context

Estimated specialty board-certified rate — Specialist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Specialist ABMS/AOA estimate

Est. board-certified rate (Specialist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Specialist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

REYMOND MEADAA, M.D. appears in the CMS NPPES registry as a Specialist provider holding M.D. credentials at 2108 TEXAS AVE STE 2061, ALEXANDRIA, LA, 71301, with a listed phone of (318) 448-1041. NPI 1669441283 was issued on 03/16/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MEADAA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 4,491 prescription claims written by this provider, covering 521 Medicare beneficiaries and totaling roughly $471K in drug spend, split 11% brand-name and 89% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Specialist is a high-volume specialty nationwide, with 69,658 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2108 TEXAS AVE STE 2061
ALEXANDRIA, LA 71301

Provider Details

NPI 1669441283
Specialty Specialist
Credentials M.D.
Gender Male
NPI Issued 03/16/2006

Hospital and facility affiliations

Facilities where REYMOND MEADAA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CENLA HEART SPECIALISTS LLC
ALEXANDRIA, LA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for REYMOND MEADAA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$284

Largest payer

Novartis Pharmaceuticals Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

REYMOND MEADAA, M.D. — brand share 11.0%
Specialty average (est.)

11% brand-name claims vs 89% generic, on 4,491 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

4,491
Total Claims
$471K
Total Drug Cost
521
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
9,872
Total Day Supply
295,446
Brand vs Generic
11% brand / 89% generic
Brand Drug Cost
$397K
Generic Drug Cost
$74K

Patient Demographics

Average Patient Age
74.4 years
Avg HCC Risk Score
1.20
Gender Split
57% female / 43% male
Age Distribution
<65: 36, 65-74: 238, 75-84: 188, 85+: 59

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What REYMOND MEADAA, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Losartan Potassium
442
Amlodipine Besylate
431
Carvedilol
428
Atorvastatin Calcium
399
Clopidogrel
Clopidogrel Bisulfate
325
Rosuvastatin Calcium
255
Xarelto
Rivaroxaban
176
Isosorbide Mononitrate Er
Isosorbide Mononitrate
171
Metoprolol Tartrate
165
Bisoprolol Fumarate
129

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Specialist Overview

How REYMOND MEADAA, M.D. fits within the Specialist landscape nationally.

69,658
Specialist Providers in US
55
States with Specialist
1,474
Avg Claims per Provider

REYMOND MEADAA, M.D.'s 4,491 claims are above the specialty average of 1,474.

Nearby Specialist Providers in Louisiana

Other clinicians with the same primary specialty enrolled in Louisiana, drawn from the same CMS NPPES roster as MEADAA.

Compare Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is REYMOND MEADAA, M.D.'s specialty?
REYMOND MEADAA, M.D. specializes in Specialist and practices in ALEXANDRIA, Louisiana. Credentials: M.D..
How much does REYMOND MEADAA, M.D. prescribe under Medicare Part D?
In 2023, REYMOND MEADAA, M.D. wrote 4,491 Medicare Part D claims totaling $471K in drug costs for 521 beneficiaries.
Where is REYMOND MEADAA, M.D. located?
REYMOND MEADAA, M.D. is located at 2108 TEXAS AVE STE 2061, ALEXANDRIA, LA, 71301. Phone: (318) 448-1041.
What is REYMOND MEADAA, M.D.'s NPI number?
REYMOND MEADAA, M.D.'s National Provider Identifier (NPI) is 1669441283, issued on 03/16/2006.
Does REYMOND MEADAA, M.D. prescribe more brand-name or generic drugs?
REYMOND MEADAA, M.D.'s prescribing is 11% brand-name and 89% generic drugs by claim count, with $397K in brand drug costs.
How many Specialist providers are there in the US?
There are 69,658 Specialist providers across 55 states in the US. The average Specialist provider writes 1,474 Medicare Part D claims per year.
What drugs does REYMOND MEADAA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, REYMOND MEADAA, M.D.'s most frequently prescribed drugs include Losartan Potassium, Amlodipine Besylate, Carvedilol. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does REYMOND MEADAA, M.D. accept Medicare?
REYMOND MEADAA, M.D. appears in CMS Medicare data with 4,491 Part D claims and 521 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify REYMOND MEADAA, M.D.'s credentials?
REYMOND MEADAA, M.D.'s NPI is 1669441283 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology